Literature DB >> 11728999

Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever.

K Keven1, E Oztas, H Aksoy, N Duman, B Erbay, S Ertürk.   

Abstract

Familial Mediterranean fever (FMF) is 1 of the major causes of secondary amyloidosis. Renal involvement is the main clinical complication and it mostly presents with nephrotic syndrome and chronic renal failure. Although deposition of amyloid has been reported in several endocrine glands such as the adrenal, thyroid, and testes, clinically significant functional impairment is uncommon. Herein, we describe a patient in whom the diagnosis of FMF was based on molecular screening and who presented with recurrent hypoglycemic attacks and extensive amyloid deposition affecting various organ function including adrenal, thyroid, parathyroid, testes, intestinal system, and the heart.

Entities:  

Mesh:

Year:  2001        PMID: 11728999     DOI: 10.1053/ajkd.2001.29295

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

1.  Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation.

Authors:  Sahru Yüksel; Lilit Ayvazyan; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

2.  Hypoadrenal syndrome in a patient with amyloidosis secondary to familial Mediterranean fever.

Authors:  Mehrnaz Asadi Gharabaghi; Aram Behdadnia; Mehrnoush Asadi Gharabaghi; Hamidreza Abtahi
Journal:  BMJ Case Rep       Date:  2013-01-29

Review 3.  Renal amyloidosis in children.

Authors:  Yelda Bilginer; Tekin Akpolat; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2011-03-01       Impact factor: 3.714

4.  Anterior hypopituitarism in a patient with amyloidosis secondary to Crohn's disease: a case report.

Authors:  Natacha Verbeke; Nathalie Pirson; Arnaud Devresse; Raluca Furnica; Thierry Duprez; Dominique Maiter
Journal:  J Med Case Rep       Date:  2018-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.